ADMA BIOLOGICS, INC. Effective Tax Rate
ADMA BIOLOGICS, INC. (ADMA) reported Effective Tax Rate of 19.60% for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-25.
Financial Statements › Expense Statement › Income Tax
us-gaap:EffectiveIncomeTaxRateContinuingOperations · last filed 2026-02-25
- ADMA BIOLOGICS, INC. effective income tax rate reconciliation, percent for the quarter ending 2024-03-31 was 3.20%.
- ADMA BIOLOGICS, INC. effective income tax rate reconciliation, percent for fiscal 2025 was 19.60%.
| Period end | Effective Income Tax Rate Reconciliation, Percent 3 month | Effective Income Tax Rate Reconciliation, Percent 6 month | Effective Income Tax Rate Reconciliation, Percent 9 month | Effective Income Tax Rate Reconciliation, Percent 12 month |
|---|---|---|---|---|
| 2025-12-31 | 19.60% 10-K · filed 2026-02-25 | |||
| 2024-09-30 | 5.70% 10-Q · filed 2024-11-07 | |||
| 2024-06-30 | 8.10% 10-Q · filed 2024-08-08 | |||
| 2024-03-31 | 3.20% 10-Q · filed 2024-05-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kodiak Sciences Inc. (KOD) | United States | $2.090B | -10.12 |
| BIOCRYST PHARMACEUTICALS INC (BCRX) | United States | $2.175B | -6.63 |
| RECURSION PHARMACEUTICALS, INC. (RXRX) | United States | $2.080B | -3.78 |
| Vericel Corp (VCEL) | United States | $2.011B | 93.97 |
| Greenland Mines Ltd (GRML) | United States | $2.362B | |
| Vir Biotechnology, Inc. (VIR) | United States | $1.814B | -6.85 |
| NOVAVAX INC (NVAX) | United States | $1.748B | -6.26 |
| Beam Therapeutics Inc. (BEAM) | United States | $2.549B | -41.51 |
| Hemab Therapeutics Holdings, Inc. (COAG) | United States | $1.672B | |
| Immunocore Holdings plc (IMCR) | $1.613B | -90.43 |